Atrial Fibrillation and Heart Failure: How Should We Manage Our Patients?
作者信息
Shahid Farhan, Lip Gregory Y H
机构信息
University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, UK.
University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, UK; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
出版信息
Arrhythm Electrophysiol Rev. 2016;5(3):162-163. doi: 10.15420/AER.2016.5.3.ED3.
Abstract
摘要
相似文献
1
Atrial Fibrillation and Heart Failure: How Should We Manage Our Patients?心房颤动与心力衰竭：我们应如何管理患者？
Arrhythm Electrophysiol Rev. 2016;5(3):162-163. doi: 10.15420/AER.2016.5.3.ED3.
2
Atrial fibrillation in patients with heart failure.心力衰竭患者的心房颤动
Curr Opin Cardiol. 2003 Jan;18(1):32-8. doi: 10.1097/00001573-200301000-00005.
3
[Atrial fibrillation as a comorbidity of heart failure].心房颤动作为心力衰竭的一种合并症
Internist (Berl). 2018 May;59(5):415-419. doi: 10.1007/s00108-018-0411-8.
4
Atrial Fibrillation, Congestive Heart Failure, and the Middle Cerebral Artery.心房颤动、充血性心力衰竭与大脑中动脉
J Neuroimaging. 1992 Oct;2(4):190-4. doi: 10.1111/jon199224190.
5
Atrial fibrillation and heart failure: a bad combination.心房颤动与心力衰竭：糟糕的组合。
Curr Opin Cardiol. 2015 Mar;30(2):161-167. doi: 10.1097/HCO.0000000000000144.
6
Atrial Fibrillation and Heart Failure in Women.心房颤动与女性心力衰竭。
Heart Fail Clin. 2019 Jan;15(1):55-64. doi: 10.1016/j.hfc.2018.08.006. Epub 2018 Oct 24.
7
Update on management of atrial fibrillation in heart failure: a focus on ablation.心力衰竭中心房颤动管理的最新进展：聚焦消融。
Heart. 2022 Mar;108(6):422-428. doi: 10.1136/heartjnl-2020-318081. Epub 2021 Jun 4.
8
[Atrial fibrillation and heart failure: cause or effect?].[心房颤动与心力衰竭：因还是果？]
Ital Heart J Suppl. 2002 Sep;3(9):899-907.
9
[Epidemiology of the relationship between atrial fibrillation and heart failure].[心房颤动与心力衰竭关系的流行病学]
Pan Afr Med J. 2017 Mar 2;26:116. doi: 10.11604/pamj.2017.26.116.11470. eCollection 2017.
10
NT-proBNP cut-off value for ruling out heart failure in atrial fibrillation patients - A prospective clinical study.用于排除心房颤动患者心力衰竭的 NT-proBNP 截断值 - 一项前瞻性临床研究。
Am J Emerg Med. 2023 Sep;71:18-24. doi: 10.1016/j.ajem.2023.05.041. Epub 2023 Jun 7.
本文引用的文献
1
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南：欧洲心脏病学会（ESC）急性和慢性心力衰竭诊断与治疗工作组编写，欧洲心脏病学会心力衰竭协会（HFA）提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
2
Atrial fibrillation.心房颤动。
Nat Rev Dis Primers. 2016 Mar 31;2:16016. doi: 10.1038/nrdp.2016.16.
3
β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.伴或不伴心力衰竭的心房颤动患者使用β受体阻滞剂与全国队列研究中的死亡率的关联
Circ Heart Fail. 2016 Feb;9(2):e002597. doi: 10.1161/CIRCHEARTFAILURE.115.002597.
4
Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes.射血分数降低与保留型心力衰竭所致心房颤动：死亡及不良结局的系统评价与荟萃分析
Int J Cardiol. 2016 Jan 15;203:660-6. doi: 10.1016/j.ijcard.2015.10.220. Epub 2015 Oct 28.
5
Should β-blockers be used in patients with heart failure and atrial fibrillation?心力衰竭合并心房颤动的患者应该使用β受体阻滞剂吗？
Clin Ther. 2015 Oct 1;37(10):2215-24. doi: 10.1016/j.clinthera.2015.08.017. Epub 2015 Sep 29.
6
Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials.伴有心房颤动和心力衰竭的患者的非维生素 K 拮抗剂口服抗凝剂（NOACs）：随机试验的系统评价和荟萃分析。
Eur J Heart Fail. 2015 Nov;17(11):1192-200. doi: 10.1002/ejhf.343. Epub 2015 Sep 3.
7
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.β 受体阻滞剂在心力衰竭合并心房颤动患者中的疗效：一项个体化患者数据分析荟萃分析。
Lancet. 2014 Dec 20;384(9961):2235-43. doi: 10.1016/S0140-6736(14)61373-8. Epub 2014 Sep 2.
8
Outcomes of medicare beneficiaries with heart failure and atrial fibrillation.患有心力衰竭和心房颤动的医疗保险受益人的治疗结果。
JACC Heart Fail. 2014 Feb;2(1):41-8. doi: 10.1016/j.jchf.2013.11.002. Epub 2014 Jan 25.
9
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会基金会/美国心脏协会实践指南工作组关于心力衰竭管理的指南：美国心脏病学会基金会/美国心脏协会报告
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239. doi: 10.1016/j.jacc.2013.05.019. Epub 2013 Jun 5.
10
Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.醛固酮受体拮抗剂与伴有左心室功能障碍的心房颤动患者的心血管死亡率：来自心房颤动和充血性心力衰竭试验的观察。
Circ Heart Fail. 2012 Sep 1;5(5):586-93. doi: 10.1161/CIRCHEARTFAILURE.111.965160. Epub 2012 Jul 12.
Zotero 插件